Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OXYCODONE Cause Product formulation issue? 73 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Product formulation issue have been filed in association with OXYCODONE (Oxycodone Hydrochloride). This represents 0.0% of all adverse event reports for OXYCODONE.

73
Reports of Product formulation issue with OXYCODONE
0.0%
of all OXYCODONE reports
1
Deaths
4
Hospitalizations

How Dangerous Is Product formulation issue From OXYCODONE?

Of the 73 reports, 1 (1.4%) resulted in death, 4 (5.5%) required hospitalization, and 1 (1.4%) were considered life-threatening.

Is Product formulation issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OXYCODONE. However, 73 reports have been filed with the FAERS database.

What Other Side Effects Does OXYCODONE Cause?

Drug dependence (104,927) Pain (55,423) Overdose (51,222) Emotional distress (49,050) Drug withdrawal syndrome (36,595) Death (23,259) Toxicity to various agents (17,518) Drug abuse (11,835) Drug ineffective (7,451) Depression (6,871)

What Other Drugs Cause Product formulation issue?

MINOXIDIL (1,369) LEVOTHYROXINE (740) AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (174) OMEPRAZOLE (99) METHYLPHENIDATE (78) ACETAMINOPHEN\HYDROCODONE (62) ACETAMINOPHEN\OXYCODONE (61) ACETAMINOPHEN (59) BUPROPION (59) CLONAZEPAM (50)

Which OXYCODONE Alternatives Have Lower Product formulation issue Risk?

OXYCODONE vs OXYCODONE TEREPHTHALATE OXYCODONE vs OXYCODONE\OXYCODONE OXYCODONE vs OXYCONTIN OXYCODONE vs OXYGEN OXYCODONE vs OXYMETAZOLINE

Related Pages

OXYCODONE Full Profile All Product formulation issue Reports All Drugs Causing Product formulation issue OXYCODONE Demographics